Synaptics ends the week with a sharply split picture: shorts are covering at the fastest monthly pace in this cycle, yet options traders remain more defensive than at any point in recent memory, and the analyst community just delivered fresh contradictory signals in a 48-hour span.
The short-covering story is the week's clearest directional move. Short interest has fallen 24% over the past month, dropping to 9.8% of the free float — down from above 12% in mid-May. That retreat accelerated this week, with a further 10.5% decline in shares short. The borrow market tells a complementary story: availability has loosened to 261% of outstanding short interest, its widest reading of the past year, up from 130% at the May trough. Cost to borrow holds flat near 0.48% — barely above zero — confirming this is an orderly unwind, not a squeeze. Shorts are leaving voluntarily, not being forced out.
Options positioning flatly contradicts that de-risking narrative. The put/call ratio printed 0.64 on Tuesday, more than three standard deviations above its 20-day mean of 0.37 — a reading that has only been higher once in the past year. For context, for the entire month of May the PCR barely exceeded 0.33. The spike began abruptly on June 29, the same day Deutsche Bank downgraded the stock. That timing is hard to ignore: options buyers appear to be hedging specifically against the analyst revision cycle, not against a broader semiconductor selloff. Most correlated peers finished the week mixed — fell 9.5%, dropped 16%, while and each gained roughly 6% — suggesting this is a SYNA-specific positioning story rather than a sector-wide rotation.
The Street itself is divided almost cleanly down the middle right now. Deutsche Bank downgraded to Hold on June 29, keeping its $125 target unchanged. Barclays also stepped back — from Overweight to Equal-Weight — though it raised its target from $110 to $135. Both moves followed the coordinated downgrade wave last Friday, when Rosenblatt, Susquehanna, and Needham all pulled their Buy ratings in a single session. Against that backdrop, Mizuho's action this morning stands out: the firm maintained its Outperform rating and raised its target sharply from $128 to $170, implying roughly 37% upside from the current $124.23 close. That is a meaningful outlier call — the only aggressively bullish revision in a week dominated by caution. The bull case rests on the Google partnership, edge AI processor adoption, and the onsemi acquisition adding strategic scale. Bears point to execution risk around the deal close, heavy China revenue exposure, and a Hold-dominated consensus that now counts just two Buy ratings from 13 analysts. The 12-month forward EPS growth factor ranks in the 97th percentile of the broader universe, reflecting sharp upward estimate revisions — yet the short score, while falling (from 64 a week ago to 59 now), still places the stock in the more-shorted half of the market.
The stock recovered 5.8% on Tuesday alone, retracing part of last week's 7.6% weekly decline and the 9.5% monthly drop. August 6 is the next scheduled earnings date — and given the prior print delivered a 17% next-day gain and a 21% five-day move, the question heading into that report is whether the newly cautious consensus is already priced in, or whether the options market's defensive posture signals something the fundamentals have not yet reflected.
See the live data behind this article on ORTEX.
Open SYNA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
